An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
基本信息
- 批准号:9754473
- 负责人:
- 金额:$ 76.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-08 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgitationAnimalsAreaBasal GangliaBehaviorBehavior assessmentBrainCellular PhoneCharacteristicsCicatrixClinicalCognitiveDataDepressed moodDiagnosisDiagnosticDiffusionDiseaseDisease remissionDyskinetic syndromeEarly DiagnosisEnvironmentExhibitsFatigueFunctional Magnetic Resonance ImagingGoalsGrainHeterogeneityHumanIndividualLaboratoriesLeadLinkLongitudinal StudiesMajor Depressive DisorderMeasurementMeasuresMediatingMental DepressionMotorMovementNational Institute of Mental HealthParkinson DiseasePatientsPhenotypePreventionProcessPublic HealthRelapseReportingResearchResearch Domain CriteriaRestRiskRoleSchizophreniaSeveritiesSignal TransductionStructureSymptomsSystemTestingTextText MessagingTimeWorkactigraphybasebehavior measurementclinical practiceclinically significantcost effectivedepressive symptomsfollow up assessmentfollow-upgraph theoryhealth economicsinnovationlongitudinal designmotor symptommultimodalityneural circuitneuroimagingneuromechanismnovelprospectiverecruitrelapse predictionsymptom clustersymptomatologytooltreatment responsetreatment strategywhite matter
项目摘要
Project Summary
Major depressive disorder (MDD) is a serious public health problem that has, at best, modest treatment
response. One reason for this mixed efficacy is that MDD has a very heterogeneous clinical presentation. One
way to parse the heterogeneity is to investigate the role of particular features of MDD, an endeavor that can
also help identify novel and focal targets for treatment and prevention efforts. Psychomotor disturbance (e.g.,
psychomotor agitation [PmA] and retardation [PmR]) has long been viewed as a particularly pernicious feature
of MDD, and yet we know surprisingly little about these behaviors. For example, it is unknown if motor
disturbance occurs only in active depression, or whether it also continues into remission (potentially signaling
vulnerability for relapse). There also has been little work (a) linking PmA & PmR with abnormal neural circuitry
mediating these motor behaviors, (b) examining how motor symptoms change over the course of illness, and
(c) investigating whether PmR & PmA represent a single underlying process, or reflect distinct mechanisms.
The present proposal seeks to test these questions and also identify powerful and easy to administer
tools to assess these behaviors in clinical practice. The proposed project will recruit those with current MDD (n
= 100), remitted MDD (n = 100) and controls (n = 50) and take a Research Domain Criteria (RDoC) approach
by comparing the three groups on multiple indicators of PmR and PmA (Aim 1). Specifically, we will assess
PmR and PmA with self and observer- based reports, behavioral assessments in the laboratory (Velocity
Scaling [PmR] and Force Variability [PmA]), and behavioral assessments in subjects' natural environment
(actigraphy and daily typing behavior on one's smartphone [texting, emailing, etc.]). These behavioral
measures are particularly critical as they yield more fine-grained and objective assessments of PmR and PmA
that may be missed by traditional diagnostic assessments. Aim 2 seeks to examine the structural (diffusion
tensor) and functional (resting state fMRI) connectivity of motor circuitry of the three groups as well as the
relation between motor circuitry and the proposed indicators of PmR and PmA. For this aim, we will utilize
innovative graph theory metrics of connectivity of the three primary motor circuits identified in animal and
human studies (specifically, basal ganglia, cerebellar and cortico-cortical motor circuits) which will provide a
comprehensive examination of motor system organization in MDD. Aim 3 seeks to follow-up subjects three
times over 18 months to evaluate whether motor symptoms change in tandem with overall depressive
symptoms and functioning over time and/or whether baseline PmR/PmA predicts course of depression an
functoining. Aim 3 is particularly clinically significant. Finding that motor and overall depression severity co-
vary over time, or that motor variables predict subsequent change in overall depression severity, would support
the potential clinical utility of the proposed novel, reliable, and easily administered motor assessments.
项目摘要
重度抑郁症(MDD)是一个严重的公共卫生问题,最多只能得到适度的治疗
反应这种混合疗效的一个原因是MDD具有非常异质的临床表现。一
解析异构性的一种方法是研究MDD的特定特性的作用,这种奋进可以
还有助于确定治疗和预防工作的新的重点目标。精神障碍(例如,
精神激动[PmA]和迟滞[PmR])长期以来一直被视为一种特别有害的特征
但我们对这些行为知之甚少。例如,不知道发动机是否
干扰只发生在活动性抑郁症,或者它是否也持续到缓解(潜在的信号
易复发)。也有很少的工作(a)连接PmA和PmR与异常的神经回路
调节这些运动行为,(B)检查运动症状在疾病过程中如何变化,和
(c)研究PmR和PmA是否代表一个单一的潜在过程,或反映不同的机制。
目前的建议旨在测试这些问题,并确定强大的和易于管理的
在临床实践中评估这些行为的工具。拟议项目将招募当前MDD(n
= 100)、缓解MDD(n = 100)和对照组(n = 50),并采用研究领域标准(RDoC)方法
比较三组PmR和PmA的多项指标(目的1)。具体而言,我们将评估
PmR和PmA与自我和基于观察者的报告,实验室行为评估(Velocity
标度[PmR]和力变异性[PmA]),以及受试者自然环境中的行为评估
(活动记录和智能手机上的日常打字行为[发短信,发电子邮件等])。这些行为
这些指标尤其重要,因为它们可以对PmR和PmA进行更细粒度和更客观的评估
这可能被传统的诊断方法所忽略。目标2旨在检查结构(扩散
张量)和功能(静息状态fMRI)连接的运动电路的三个组,以及
运动电路与PmR和PmA的建议指标之间的关系。为此,我们将利用
在动物和哺乳动物中识别的三个主要运动回路连通性的创新图论指标
人类研究(特别是基底神经节、小脑和皮质-皮质运动回路),
MDD患者运动系统组织的全面检查。目标3寻求对主题三采取后续行动,
时间超过18个月,以评估运动症状的变化是否与整体抑郁症
随着时间的推移,症状和功能和/或基线PmR/PmA是否预测抑郁症的病程,
functoining。目标3在临床上尤其重要。发现运动和整体抑郁症的严重程度-
随着时间的推移而变化,或者运动变量预测整体抑郁严重程度的后续变化,将支持
所提出的新颖、可靠且易于管理的运动评估的潜在临床效用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIJAY A MITTAL其他文献
VIJAY A MITTAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIJAY A MITTAL', 18)}}的其他基金
2/5 CAPER Computerized assessment of psychosis risk
2/5 CAPER 精神病风险的计算机化评估
- 批准号:
10592322 - 财政年份:2020
- 资助金额:
$ 76.76万 - 项目类别:
2/5 CAPER Computerized assessment of psychosis risk
2/5 CAPER 精神病风险的计算机化评估
- 批准号:
9978241 - 财政年份:2020
- 资助金额:
$ 76.76万 - 项目类别:
2/5 CAPER Computerized assessment of psychosis risk
2/5 CAPER 精神病风险的计算机化评估
- 批准号:
10399414 - 财政年份:2020
- 资助金额:
$ 76.76万 - 项目类别:
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation Study
阴性症状前驱清单 (PINS):开发和验证研究
- 批准号:
10320426 - 财政年份:2019
- 资助金额:
$ 76.76万 - 项目类别:
An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
- 批准号:
10374003 - 财政年份:2019
- 资助金额:
$ 76.76万 - 项目类别:
An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
- 批准号:
9910463 - 财政年份:2019
- 资助金额:
$ 76.76万 - 项目类别:
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation Study
阴性症状前驱清单 (PINS):开发和验证研究
- 批准号:
10031573 - 财政年份:2019
- 资助金额:
$ 76.76万 - 项目类别:
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation Study
阴性症状前驱清单 (PINS):开发和验证研究
- 批准号:
10528461 - 财政年份:2019
- 资助金额:
$ 76.76万 - 项目类别:
An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
- 批准号:
10596065 - 财政年份:2019
- 资助金额:
$ 76.76万 - 项目类别:
2/3 Community psychosis risk screening: An instrument development study
2/3 社区精神病风险筛查:仪器开发研究
- 批准号:
10216970 - 财政年份:2017
- 资助金额:
$ 76.76万 - 项目类别:
相似海外基金
Effects of dexmedetomidine on agitation in critically ill TBI patients - DEX-TBI
右美托咪定对危重 TBI 患者躁动的影响 - DEX-TBI
- 批准号:
488402 - 财政年份:2023
- 资助金额:
$ 76.76万 - 项目类别:
Operating Grants
Relationship between Biomarkers of Oxidative Stress and Agitation Severity in Moderate-to-severe Alzheimer's Disease
中重度阿尔茨海默病氧化应激生物标志物与躁动严重程度之间的关系
- 批准号:
497994 - 财政年份:2023
- 资助金额:
$ 76.76万 - 项目类别:
Co-design and evaluation of sensor-instrumented ‘smart socks’ (MPATIX) to improve management of distress and agitation for people with dementia
共同设计和评估传感器仪表“智能袜子”(MPATIX),以改善痴呆症患者的痛苦和躁动管理
- 批准号:
10055596 - 财政年份:2023
- 资助金额:
$ 76.76万 - 项目类别:
Collaborative R&D
Identifying pre-agitation biometric signature in dementia patients: A feasibility study
识别痴呆症患者的躁动前生物识别特征:可行性研究
- 批准号:
486612 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Studentship Programs
Relationship between 4-Hydroxynonenal and Agitation Severity in Alzheimer’s Disease
4-羟基壬烯醛与阿尔茨海默病患者躁动严重程度之间的关系
- 批准号:
486589 - 财政年份:2022
- 资助金额:
$ 76.76万 - 项目类别:
Studentship Programs
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10404523 - 财政年份:2021
- 资助金额:
$ 76.76万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10683499 - 财政年份:2021
- 资助金额:
$ 76.76万 - 项目类别:
Development of Memesto, a wearable repetitive message and music therapy device that senses and reduces agitation in persons with AD/ADRD.
开发 Memesto,一种可穿戴式重复信息和音乐治疗设备,可感知并减少 AD/ADRD 患者的躁动。
- 批准号:
10322846 - 财政年份:2021
- 资助金额:
$ 76.76万 - 项目类别:
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10190522 - 财政年份:2021
- 资助金额:
$ 76.76万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10365272 - 财政年份:2021
- 资助金额:
$ 76.76万 - 项目类别: